IOVANCE BIOTHERAPEUTICS INC (IOVA) Stock Balance Sheet
NASDAQ:IOVA • US4622601007
Current stock price
3.96 USD
-0.11 (-2.7%)
At close:
4.04 USD
+0.08 (+2.02%)
Pre-Market:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 163.08M | 115.69M | 114.89M | 231.70M | 78.20M | |||
| Marketable Securities | 133.90M | 208.09M | 164.98M | 240.10M | 426.20M | |||
| Receivables | 82.45M | 69.34M | 151.00K | N/A | N/A | |||
| Inventories | 51.68M | 51.52M | 10.37M | N/A | N/A | |||
| Other Current Assets | 11.58M | 12.38M | 17.46M | 7.30M | 3.50M | |||
| Total Current Assets | 442.69M | 457.02M | 307.85M | 479.10M | 508.00M | |||
| Non-Current Assets | ||||||||
| PPE Net | 177.01M | 164.28M | 176.54M | 178.20M | 169.90M | |||
| Investments And Advances | N/A | N/A | N/A | 0.00 | 91.60M | |||
| Intangibles | 279.32M | 282.40M | 229.26M | N/A | N/A | |||
| Other Non-Current Assets | 14.15M | 6.73M | 66.70M | 6.60M | 7.90M | |||
| Total Non-Current Assets | 470.48M | 453.41M | 472.50M | 184.90M | 269.30M | |||
| TOTAL ASSETS | 913.17M | 910.43M | 780.35M | 664.00M | 777.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 1.00M | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 115.20M | 94.83M | 77.18M | 64.90M | 61.80M | |||
| Accounts Payable | 22.16M | 27.51M | 33.12M | 26.60M | 27.40M | |||
| Total Current Liabilities | 138.36M | 122.34M | 110.31M | 91.50M | 89.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 1.00M | 1.00M | 1.00M | 1.00M | |||
| Deferred Taxes/Income | 31.83M | 32.31M | 17.35M | N/A | N/A | |||
| Other Non-Current Liabilities | 44.40M | 44.37M | 67.08M | 71.90M | 65.50M | |||
| Total Non-Current Liabilities | 76.23M | 77.68M | 85.43M | 72.80M | 66.50M | |||
| TOTAL LIABILITIES | 214.59M | 200.02M | 195.74M | 164.30M | 155.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.78B | -2.38B | -2.01B | -1.57B | -1.17B | |||
| Additional Paid In Capital | 3.46B | 3.10B | 2.59B | 2.07B | 1.79B | |||
| Common Shares | 19.00K | 16.00K | 14.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 16.44M | -1.05M | 2.53M | -900.00K | -600.00K | |||
| Shares Outstanding | 411.94M | 305.25M | 256.14M | 187.80M | 157.00M | |||
| Tangible Book Value per Share | 1.02 | 1.40 | 1.39 | 2.66 | 3.96 | |||
| Total Shareholders' Equity | 698.58M | 710.40M | 584.61M | 499.60M | 621.70M | |||
| TOTAL LIABILITIES AND EQUITY | 913.17M | 910.43M | 780.35M | 664.00M | 777.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Ratio | 3.20 | 3.74 | 2.79 | 5.24 | 5.70 | |||
| Return On Assets (ROA) | -42.82% | -40.88% | -56.90% | -59.62% | -44.03% | |||
| Return On Equity (ROE) | -55.97% | -52.39% | -75.95% | -79.24% | -55.05% | |||
All data in USD , ROIC based on taxRate of 0.21